Business News

Agfa-Gevaert reports third quarter results – Regulated information

Friday 30. October 2009 - Decrease in Group sales of 8.1 percent; Recurring EBIT amounted to 43 million Euro - significant improvement versus the third quarter of 2008 (27 million Euro) and the second quarter of 2009 (38 million Euro); Operating result nearly doubled versus the third quarter of 2008; Continued decrease of SG&A costs - ahead of previously announced plans; Positive net result of 4 million Euro; Further strong net financial debt reduction to 500 million Euro - Improvement of 350 million Euro over 2-year period

Euro millions Q3 2008 Q3 2009 % change
Net Sales 741 681 -8.1%
Gross Profit (*) 223 220 -1.3%
% of sales 30.1% 32.3%
Recurring EBITDA (*) 54 68 +25.3%
% of sales 7.3% 10.0%
Recurring EBIT (*) 27 43 +59.3%
% of sales 3.6% 6.3%
Operating result 19 36 +89.5%
Net result (13) 4 +130.8%
Net operating cash flow 24 55 +129.2
(*) before restructuring and non-recurring items.
Compared to the third quarter of 2008, Group sales decreased 8.1 percent to 681 million Euro, which indicates that the crisis-driven decline in Agfa-Gevaert’s markets is bottoming-out.
The Group’s recurring gross profit margin improved from 30.1 percent in the third quarter of 2008 to 32.3 percent. It was positively influenced by efficiency programs, lower raw material prices and certain one-off effects and negatively impacted by manufacturing inefficiencies due to lower use of capacity.
Continuing its strict cost management, Agfa-Gevaert further reduced its Selling and General Administration expenses. The average monthly SG&A expense was brought down from 51 million Euro in the third quarter of 2008, to 44 million Euro in the third quarter of 2009, which is a cost decrease by 13.7 percent. The SG&A expenses represented 19.4 percent of sales, versus 20.8 percent in the third quarter of 2008.
The Group’s recurring EBITDA (the sum of Graphics, HealthCare, Specialty Products and the unallocated portion) increased from 54 million Euro in the third quarter of 2008 to 68 million Euro. Recurring EBIT increased strongly from 27 million Euro to 43 million Euro.
The restructuring and non-recurring items resulted in an expense of 7 million Euro, versus 8 million Euro in the third quarter of 2008.
As in the first half of 2009, the non-operating result was affected by pension provisions (mainly concerning inactives), to cover for increased pension deficits in theUSAand theUK. The non-operating result amounted to minus 23 million Euro.
Taxes amounted to 8 million Euro, the same as in the third quarter of 2008.
The net result amounted to 4 million Euro, compared to minus 13 million Euro in the third quarter of 2008.
Balance sheet and cash flow
At the end of September 2009, total assets were 2,931 million Euro, compared to 3,160 million Euro at the end of 2008.
Inventories were 514 million Euro (or 97 days). Trade receivables (including deferred revenue and advanced payments) amounted to 532 million Euro, or 70 days and trade payables were 190 million Euro, or 36 days.
Notwithstanding the limited impact of the securitization program, net financial debt improved to 500 million Euro at the end of September 2009, compared to 569 million Euro at the end of June 2009. Net financial debt improved by 350 million Euro over the past 2 years.
Net operating cash flow amounted to 55 million Euro.
Agfa Graphics – third quarter
Euro millions Q3 2008 Q3 2009 % change
Net Sales 377 344 -8.8%
Recurring EBITDA (*) 28.7 30.1 +4.9%
% of sales 7.6% 8.8%
Recurring EBIT (*) 15.7 19.1 +21.7%
% of sales 4.2% 5.6%
(*) before restructuring and non-recurring items.
Agfa Graphics’ sales decreased 8.8 percent versus last year’s third quarter. Both the market environment and the activity levels were in line with the second quarter, but sales were positively influenced by certain one-off effects.
Profitability was positively impacted by efficiency programs, by lower raw material prices and by the above mentioned one-off effects. Negative effects came from the underutilization of the manufacturing capacity, bad debt provisions and competitive pressure. Compared to the third quarter of 2008, Agfa Graphics further reduced its Sales and General Administration expense with 9 million Euro.
The recurringEBITDA margin amounted to 8.8 percent of sales. The recurring EBIT margin increased to 5.6 percent of sales.
In prepress, Agfa Graphics received its first order for :N92v printing plates from the Chinese Guangzhou Daily, one of the world’s top 100 daily newspapers. Furthermore, Agfa Graphics supplied an :Avalon N8 platesetter to Sungwon Adpia, the largest consumer of Computer-to-Plate printing plates in the Korean Printing industry.
InNorway, Agfa Graphics signed an important contract with Hjemmet Mortensen Trykkeri AS, the largest printer in the country. The deal includes the installation of two :Avalon N16 platesetters, a service contract as well as a three-year contract for :Energy Elite printing plates. Agfa Graphics also signed an exclusive 5-year printing plate contract with Roularta Media Group, a majorBelgian-French publishing and printing firm.
Also in prepress, Agfa Graphics announced the signing of an agreement with Kemtek Imaging Systems Ltd. for the distribution, service and support of Agfa Graphics’ product range for commercial printers inSouthern Africa.
In industrial inkjet, Agfa Graphics’ next generation range of :Anapurna large-format printers continued the success of the last quarters. With contracts signed all over the world, Agfa Graphics was able to expand its market position in the large-format segment.
Furthermore, Agfa Graphics introduced new features for its :Dotrix Modular inkjet press. The new Express Print Mode increases the press’ productivity by 35 percent. The second feature expands the :Dotrix Modular’s color gamut.
In theUSA, Digital Packaging Solutions recently installed Agfa Graphics’ :Dotrix Modular press. The system enables the company to deliver on-demand services for the packaging industry.
The world’s first :M-Press Tiger was successfully installed at the SMP Group inLondon. The :M-Press Tiger is the second generation of the :M-Press industrial flatbed press. In recent months, various orders were booked for Agfa Graphics’ high-end inkjet press.
Agfa HealthCare – third quarter
Euro millions Q3 2008 Q3 2009 % change
Net Sales 291 275 -5.5%
Recurring EBITDA (*) 20.7 35.4 +71.0%
% of sales 7.1% 12.9%
Recurring EBIT (*) 6.7 22.7 +238.8%
% of sales 2.3% 8.3%
(*) before restructuring and non-recurring items.
In line with the previous quarter, Agfa HealthCare’s sales decreased by 5.5 percent to 275 million Euro. The market environment and the activity levels were in line with the previous quarter.
The business group’s profitability showed considerable improvement. In the Imaging segment, this was mainly due to lower raw material prices and increased operational efficiency. In the IT segment the main reasons were the growth of the business, its improved SG&A cost position and its improved service efficiency. Agfa HealthCare’s recurring EBITDA amounted to 35.4million Euro (or 12.9percent of sales). Recurring EBIT improved strongly to 22.7 million Euro, or 8.3 percent of sales.
In the field of Imaging, Agfa HealthCare successfully completed the first installation of its DX-D 500 Direct Radiography system (DR) at the Dortmund Knappschaftskrankenhaus (Germany). The DX-D 500 is a complete DR solution, suited for a very comprehensive range of X-ray examinations. A series of new contracts in – amongst other countries -France,GermanyandSpainhave been signed in the third quarter.
In Imaging Informatics, the U.S. Air Force selected Agfa HealthCare’sIMPAXDataCenterto manage and share clinical information and images across all of the USAF’s medical facilities in theUnited States. Over the years, Agfa HealthCare has built a strong presence in theU.S.military and Veterans Affairs hospitals and medical treatment facilities. InCanada, the Centre Hospitalier Universitaire de Québec (CHUQ) has successfully implemented Agfa HealthCare’s IMPAX 6 Picture Archiving and Communication System. As an integral part of the Quebec Government’s eHealth initiative, IMPAX 6 has helped CHUQ move to digital radiology.
As part of the United Arab Emirates Ministery of Health’s national health information system program, Agfa HealthCare will install its IMPAX 6 solution as well as a number of Computed Radiography solutions at 34 healthcare facilities.
In Enterprise IT, the interfaces between Agfa HealthCare’s leading Hospital and Clinical Information System ORBIS and SAP Controlling, SAP Material Management and SAP Financial have been officially certified by SAP. The interfaces are used to bidirectionally transfer data from ORBIS to SAP.
In recent months, Agfa HealthCare was able to strengthen its presence in the Enterprise IT markets inGermany(e.g. SLK Kliniken Heilbronn GmbH), France (e.g. Centre Hospitalier Du Mans and Centre Hospitalier Intercommunal Créteil) andLuxembourg(e.g. Centre Hospitalier de Luxembourg and Centre Hospitalier Emile Mayrisch).
Agfa Specialty Products – third quarter
Euro millions Q3 2008 Q3 2009 % change
Net Sales 73 62 -15.1%
Recurring EBITDA (*) 6.0 4.8
-20.0%
% of sales 8.2% 7.7%
Recurring EBIT (*) 5.0 3.7 -26.0%
% of sales 6.8% 6.0%
(*) before restructuring and non-recurring items.
Agfa Specialty Products’ sales decreased 15.1 percent compared to the third quarter of 2008. The activity levels were in line with the second quarter, but sales were positively impacted by an important delivery as part of the Moroccan ID cards contract.
Agfa Specialty Products’ profitability continued to be negatively impacted by the further market-driven decline of Classic Film products sales and by the investments in New Business. The recurring EBITDA margin amounted to 7.7 percent of sales and the recurring EBIT margin to 6.0 percent of sales.
Results after nine months
Agfa-Gevaert Group – year to date
Euro millions 9m 2008 9m 2009 % change
Net Sales 2,271 2,020 -11.1%
Gross Profit (*) 732 642 -12.3%
% of sales 32.2% 31.8%
Recurring EBITDA (*) 191 187 -2.1%
% of sales 8.4% 9.3%
Recurring EBIT (*) 104 109 +4.8%
% of sales 4.6% 5.4%
Operating result 80 99 +23.8%
Net result – (14)
Net operating cash flow 9 187
(*) before restructuring and non-recurring items.
Agfa Graphics – year to date
Euro millions 9m 2008 9m 2009 % change
Net Sales 1,140 985 -13.6%
Recurring EBITDA (*) 86.0 67.5 -21.5%
% of sales 7.5% 6.9%
Recurring EBIT (*) 46.7 32.5 -30.4%
% of sales 4.1% 3.3%
(*) before restructuring and non-recurring items.

Agfa HealthCare – year to date
Euro millions 9m 2008 9m 2009 % change
Net Sales 898 861 -4.1%
Recurring EBITDA (*) 86.9 116.6 +34.2%
% of sales 9.7% 13.5%
Recurring EBIT (*) 42.6 76.7 +80.0%
% of sales 4.7% 8.9%
(*) before restructuring and non-recurring items.
Agfa Specialty Products – year to date
Euro millions 9m 2008 9m 2009 % change
Net Sales 233 174 -25.3%
Recurring EBITDA (*) 20.0 12.9 -35.5%
% of sales 8.6% 7.4%
Recurring EBIT (*) 16.3 9.7 -40.5%
% of sales 7.0% 5.6%
(*) before restructuring and non-recurring items.
Outlook
For the rest of the year, the Agfa-Gevaert Group does not expect major changes in the market environment.
(end of message)
Management Certification of Financial Statements and Quarterly Report
This statement is made in order to comply with new European transparency regulation enforced by the Belgian Royal Decree of14 November 2007and in effect as of 2008.
“The Board of Directors and the Executive Committee of Agfa-Gevaert NV, represented by Mr. Julien De Wilde, Chairman of the Board of Directors, Mr. Jo Cornu, President and CEO, and Mr. Kris Hoornaert, CFO, jointly certify that, to the best of their knowledge, the interim consolidated financial statements included in the interim report and based on the relevant accounting standards, fairly present in all material respects the financial condition and results of Agfa-Gevaert NV, including its consolidated subsidiaries. Based on our knowledge, the interim report includes all information that is required to be included in such document and does not omit to state all necessary material facts.”
Statement of risk
This statement is made in order to comply with new European transparency regulation enforced by the Belgian Royal Decree of14 November 2007and in effect as of 2008.
“As with any company, Agfa is continually confronted with – but not exclusively – a number of market and competition risks or more specific risks related to the cost of raw materials, product liability, environmental matters, proprietary technology or litigation.
Agfa believes that the most noteworthy risks facing the company for the coming quarters would be the effects of the continued economic crisis on its key markets.”
Key risk management data is provided in the annual report (p.30) available on www.agfa.com.